Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Iovance Biotherapeutics (IOVA) over the last 2 years, with Sep 2025 value amounting to 0.28.

  • Iovance Biotherapeutics' Asset Utilization Ratio was N/A to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28, marking a year-over-year change of. This contributed to the annual value of 0.19 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Asset Utilization Ratio is 0.28, which was up 7.22% from 0.26 recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Asset Utilization Ratio ranged from a high of 0.28 in Q3 2025 and a low of -0.00 during Q2 2023.
  • In the last 3 years, Iovance Biotherapeutics' Asset Utilization Ratio had a median value of 0.00 in 2024 and averaged 0.11.
  • Data for Iovance Biotherapeutics' Asset Utilization Ratio shows a peak YoY spiked of 9,719.44% (in 2025) over the last 5 years.
  • Over the past 3 years, Iovance Biotherapeutics' Asset Utilization Ratio (Quarterly) stood at 0.00 in 2023, then reached 0.00 in 2024, then surged by 9,719.44% to 0.28 in 2025.
  • Its Asset Utilization Ratio was 0.28 in Q3 2025, compared to 0.26 in Q2 2025 and 0.23 in Q1 2025.